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Abstract
Superparamagnetic iron oxide nanoparticles (SPION) are
being widely used for various biomedical applications, for
example, magnetic resonance imaging, targeted delivery of
drugs or genes, and in hyperthermia. Although, the potential
benefits of SPION are considerable, there is a distinct need
to identify any potential cellular damage associated with
these nanoparticles. Besides focussing on cytotoxicity, the
most commonly used determinant of toxicity as a result of
exposure to SPION, this review also mentions the impor-
tance of studying the subtle cellular alterations in the form of
DNA damage and oxidative stress. We review current studies
and discuss how SPION, with or without different surface
coating, may cause cellular perturbations including modula-
tion of actin cytoskeleton, alteration in gene expression
profiles, disturbance in iron homeostasis and altered cellular
responses such as activation of signalling pathways and
impairment of cell cycle regulation. The importance of
proteinSPION interaction and various safety considera-
tions relating to SPION exposure are also addressed.
Keywords: SPION; cellular stress; cytotoxicity; DNA damage
S
uperparamagnetic iron oxide nanoparticles
(SPION), the only clinically approved metal oxide
nanoparticles (NPs), hold immense potential in a
vast variety of biomedical applications such as magnetic
resonance imaging (MRI), targeted delivery of drugs or
genes, tissue engineering, targeted destruction of tumour
tissue through hyperthermia, magnetic transfections, iron
detection, chelation therapy and tissue engineering (16).
The SPIO agents have a unique property of superpar-
amagnetism that confers advantages such as the genera-
tion of heat in alternating magnetic fields; or an ability to
be guided to a specific tissue or organ by an external
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magnetic field. This property is therefore central to the
exploitation of SPIO in many of the above-mentioned
technological and biomedical applications.
Common to all NPs, SPION are associated with
unique physico-chemical features, such as nanometre
sizes and a large surface area to mass ratio that also
facilitate novel applications. On the other hand, the same
nanoscale properties (e.g. large surface area coupled with
enhanced reactivity, increased propensity to diffuse
across biological membranes, and tissue barriers due to
nano-size can cause cellular stress) can potentially induce
cytotoxicity that can manifest itself by impairing the
functions of the major components of the cell, namely
mitochondria, nucleus and DNA (79). In fact, exposure
to SPION has been associated with significant toxic
effects such as inflammation, the formation of apoptotic
bodies, impaired mitochondrial function (MTT), mem-
brane leakage of lactate dehydrogenase (LDH assay)
generation of reactive oxygen species (ROS), increase in
micronuclei (indicators of gross chromosomal damage; a
measure of genotoxicity), and chromosome condensation
(1015) (Fig. 1).
SPION are divided into three main categories based on
their hydrodynamic diameter: oral SPION, 300 nm3.5
mm; standard SPION (SSPIO), 50150 nm; and ultra-
small SPION (USPIO), B50 nm (16). SPION that are
10100 nm in size are considered to be optimal for
intravenous administration whereas particles 200 nm
and B10 nm are sequestered by the spleen or removed
through renal clearance, respectively (16). However,
routes of entry and surface properties of SPION
govern their ultimate fate in terms of the efficiency of
SPION
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Fig. 1. Cellular toxicity induced by SPION. Exposure to SPION could potentially lead to toxic side effects such as membrane
leakage of lactate dehydrogenase, impaired mitochondrial function, inflammation, formation of apoptotic bodies, chromosome
condensation, generation of reactive oxygen species (ROS) and DNA damage.
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cellular uptake, biodistribution, metabolism and poten-
tial toxicity (17).
Given that iron oxides  both magnetite (Fe3O4) and
maghemite (gFe2O3)  occur naturally as nano-sized
crystals in the earth’s crust generated by various environ-
mental sources such as volcanoes and fires, it would seem
that there is no intrinsic risk associated with these NPs per
se. However, the major concern is the increased exposure
(via different routes) level to humans and the ecosystem as
more and more NPs are being manufactured to meet the
demands of the rapidly proliferating field of nanomedicine
(18). The dramatic growth and the therapeutic benefits
that SPION have to offer, accompanies the risks and
concerns associated with their exposure (19). Therefore,
there is a considerable need to address biocompatibility
and biosafety concerns associated with their usage in a
variety of applications. This review focuses on one of the
most widely used NPs in medical diagnostics, aiming to
highlight the potential adverse biological effects and safety
issues associated with SPION.
Methods of preparation
Iron oxide NPs are found naturally in the environment as
particulate matter in air pollution and in volcanic
eruptions. SPION, either Fe3O4 (magnetite) or gFe2O3
(maghemite), can not only be generated as emissions
from traffic, industry and power stations but can be
specifically synthesised chemically for a wide variety of
applications (20, 21). Various methods can be employed
in their fabrication such as classical synthesis by
co-precipitation, reactions in constrained environments,
polyol method, flow-injection synthesis and sonolysis
(2225) (Fig. 2). Once the iron oxide core has been
generated, a second tier of SPION preparation may be
utilised to coat their surfaces with biocompatible mole-
cules such as polyethylene glycol, dextran, albumin or
dendrimers (6, 2628), which can either be performed in
situ or via post-synthesis methods that require additional
steps (22). The magnetic behaviour is an important
parameter that needs to be considered when designing
and synthesising the SPION in order to maximally
facilitate their imaging and therapeutic efficacies as
high magnetisation values are required. Although this
can be accomplished by applying a maximum magnetic
field acceptable under the clinical settings, the reaction
conditions during the synthesis processes can be modu-
lated to generate particle size with a large surface area,
which in turn allows these particles to exhibit high
magnetic susceptibility (29, 30). Other alterations in the
conditions of SPION synthesis, specifically an increase in
temperature, have been shown to significantly affect not
only their magnetic properties but also hydrodynamic
diameter and shape (31). Hydrodynamic particle size is
an important parameter that influences magnetisation
values, dissolution and stability (32). Consequently,
chemical methods allow for numerous variations in
reaction conditions that can be modulated in order to
achieve SPION with desired physico-chemical properties.
A major challenge in SPION design is adequate control
of the reaction conditions to enable synthesis of particles
SPION
Air pollutant, 
volcanic eruptions
Nat
ura
l   
so
urc
e 
Chemical 
synthesis 
Various methods: 
• Co-precipitation
• Reactions in constrained 
environments
• Polyol method
• Flow-injection synthesis
• Sonolysis
Physico-chemical characteristics 
ideal for nanomedicine:
• Narrow size distribution
• High level of monodispersity 
• Homogenous composition
• High magnetic susceptibility
PEG
Dendrimers
BSA
Surface modified 
SPION to improve 
biocompatibility 
and biodistribution 
Surface coatings
Dextran
Post-
synthesis
In-situ
Uncoated SPION
Fig. 2. Methods of SPION synthesis. Various methods can be employed for the synthesis of SPION with the desired physico-
chemical characteristics. These can be also coated with biocompatible molecules either in situ or via post-synthesis methods
wherein the uncoated SPION are surface-coated subsequent to their synthesis.
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with a narrow size distribution, high level of monodis-
persity and homogenous composition (6). With regards
to the materials used for surface coating, factors such as
stability, biocompatibility, biodegradability and surface
chemistry need to be taken into consideration in order to
modestly predict their cellular interactions, cell uptake
mechanisms and steric/electrostatic interactions with
intracellular macromolecules. All these characteristics
are vital to the success of the application that the SPION
is destined for.
Surface modification
Uncoated iron oxide NPs have very low solubility that
can lead to precipitation (if not sufficiently small) due to
gravitation forces and also a high rate of agglomeration
under physiological conditions that can impede blood
vessels particularly in a clinical exposure setting. Thus,
to be used effectively for any clinical application and to
improve biocompatibility and biodistribution, SPION are
coated with an amphiphilic layer; they can also be
designed to bind to complex biological molecules such
as antibodies, peptides, hormones or drugs (15). Com-
mercially available SPION are surface coated with
materials such as silicon, dextran, citrate and PEGylated
starch and are mainly used as contrast agents in target
organs such as the gastrointestinal tract, liver, spleen and
lymph nodes (33). The derivitisation of iron oxide plays
an important role in internalisation efficiency as well as
cytotoxicity (3436).
But the stability of these coatings with regard to their
shelf-life and the consequences of their breakdown in
vitro or in vivo have not been thoroughly investigated.
Interestingly, many of the commercially available contrast
agents such as Ferridex, Resovist, Supravist and Sinerem
are coated with dextran or carboxy dextran (33), but
there is evidence to indicate that dextran coatings on iron
oxide NPs are not strongly bound and therefore more
prone to detachment leading to aggregation and
precipitation (37, 38). Although some reports have
emerged that suggest there may be a significant problem
associated with these coatings (see section on Toxicity
studies) as yet, there is still insufficient information on the
effect of these coatings on cytotoxicity associated with
DNA damage and oxidative stress.
Mechanisms associated with toxicity
SPION have attracted much attention not only because
of their superparamagnetic properties but also because
they have been shown to be associated with low toxicity
in the human body (12, 13, 39, 40). A study comparing
several metal oxide NPs in vitro demonstrated iron oxide
NPs to be safe and non-cytotoxic below 100 mg/ml (41).
Another study on normal, glia and breast cancer cells
revealed that the toxicity of Fe3O4 NPs coated with a
bipolar surfactant (tetramethylammonium 11-aminoun-
decanoate) is concentration dependent with the particles
being non-toxic in the concentration range of 0.110 mg/ml
while cytotoxicity could be seen at 100 mg/ml (42). There
are, therefore, several reports in the literature that
demonstrate that a range of SPION with varying
physico-chemical characteristics primarily demonstrate
low toxicity or cytotoxicity at doses of 100 mg/ml or
higher. The number of in vivo studies performed in
humans is however very limited, but one investigation
found that Ferumoxtran-10, a dextran-coated USPIO,
only induced side effects such as urticaria, diarrhoea and
nausea, all of which were mild and short in duration (43,
44). It is thought that this is primarily because they can
be degraded and cleared from circulation by the endo-
genous iron metabolic pathways. Iron released from
SPION is metabolised in the liver and subsequently
used in the formation of red blood cells or excreted via
kidneys (43).
Though the dose of SPION administered intravenously
accounts for 1.255% of the total body iron stores (16),
SPION are required to be magnetically targeted to a
particular tissue/organ in order to maximally benefit a
therapeutic or diagnostic application, leading to high
concentrations in a localised area. Consequently, this iron
overload can have toxic implications as excessive accu-
mulation of the SPION, and in particular, high levels of
free Fe ions in the exposed tissue can lead to an
imbalance in its homeostasis and can cause aberrant
cellular responses including cytotoxicity, DNA damage,
oxidative stress, epigenetic events and inflammatory
processes (6, 10, 11, 42). More importantly, in the absence
of cytotoxicity, this exposure can still lead to subtle but
deleterious cellular disruption in the form of DNA
damage that may initiate carcinogenesis or have a
significant impact on future generations if the fidelity of
the genome in germ cells is not maintained (45). Indeed,
iron has long been associated with cancer and several
mechanisms for iron-induced carcinogenesis have been
suggested including a generation of ROS that can
potentiate direct damage to DNA, proteins and lipid
peroxidation (4649). Iron-overload following intra-
muscular injections of an irondextran complex has
been associated with spindle cell sarcoma and pleo-
morphic sarcoma in rats (50). It is possible that these
neoplasms could be the result of a phenomenon known as
solid-state carcinogenesis, whereby implantation of a
foreign body (SPION in this case) leads to tumour
formation (51).
Another mechanism by which SPION can induce
(geno)toxicity is via the generation of ROS. Following
internalisation via a number of possible mechanisms
(Fig. 3), SPION are presumably degraded into iron ions
within the lysosomes by hydrolysing enzymes effective at
Neenu Singh et al.
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low pH (26, 52, 53). This ‘free iron’ can potentially cross
the nuclear or mitochondrial membrane and in the latter
case the free iron in the form of ferrous ions (Fe2) can
react with hydrogen peroxide and oxygen produced by the
mitochondria to produce highly reactive hydroxyl radi-
cals and ferric ions (Fe3) via the Fenton reaction:
Fe2H2O2 0 Fe
3
+
OHOH
Therefore, hydroxyl radicals generated by the free iron
could damage DNA, proteins, polysaccharides and lipids
in vivo (54). Indeed, iron overload is associated with the
production of hydroxyl radicals in rats (55), which react
with membrane lipids giving rise to breakdown products
including malondialdehyde (MDA) and 4-hydroxy-2-
nonenal (HNE), both of which can bind to DNA and
are mutagenic (56, 57) (Fig. 3). In fact, incubating iron
with rat liver nuclei or mitochondria results in the
formation of DNA strand breaks, an effect that can be
abrogated by using an iron chelator (58). Furthermore,
in vivo an increased number of DNA breaks have been
demonstrated in rats subjected to dietary iron overload,
whilst oxidative damage to DNA (measured by the
presence of 8-OH-dG adducts) have been observed in
mice administered with irondextran (59). An in vivo
study on Swiss mice using polyaspartic acid-coated
magnetite NPs demonstrated a time and dose-dependent
increase in micronucleus frequency (15).
In addition to the Fenton reaction, structural damage
to ATP-generating mitochondria by SPION localisation
or iron overload, could potentially result in anomalous
functioning of the mitochondria such as altered mem-
brane potential, cytochrome c release,
+
O2 production,
and uncoupling of oxidative phosphorylation (60, 61),
which may also contribute to the underlying mechanisms
associated with cytotoxicity. Therefore, iron overload as a
result of SPION-exposure could potentially result in
deleterious cellular consequences eventually leading to
cell death.
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Fig. 3. Schematic representation of different intracellular uptake pathways of SPION. Possible mechanisms of uptake include
passive diffusion, receptor-mediated endocytosis, clathrin-mediated endocytosis, caveolin-mediated internalisation, and other
calthrin and caveolin-independent endocytosis (105, 106). Upon internalisation, the SPION may presumably be degraded into
iron ions in the lysosomes. This ‘free iron’ can potentially cross the nuclear or mitochondrial membrane and in the latter case the
free iron in the form of ferrous ions (Fe2) can react with hydrogen peroxide and oxygen produced by the mitochondria to
produce highly reactive hydroxyl radicals and ferric ions (Fe3) via the Fenton reaction. Hydoxyl radicals (
+
OH) generated
could indirectly damage DNA, proteins and lipids (8-OH-dG8 hydroxydeoxyguanosine, MDAmalondialdehyde, HNE
4-hydroxy-2-nonenal).
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Toxicity studies
Several studies have examined the cytotoxic potential of
several different types of SPION with a range of surface
coatings and have generally found low or no cytotoxicity
associated with these NPs until high exposure levels
(100 mg/ml). The toxicity was also found to be
dependent on various factors such as type of surface-
coating or its breakdown products, chemical composition
of cell-medium, oxidation state of iron in SPION and
proteinSPION interaction (27, 28, 62, 63).
A study investigating the effect of different surface
coatings on cell behaviour and morphology have shown
that dextran-magnetite (Fe3O4) NPs result in cell death
and reduced proliferation similar to that caused by
uncoated iron oxide particles (27). The reason behind
the observed cytotoxicty with dextran-magnetite was
attributed to the breakdown of the dextran shell exposing
the cellular components to chains or aggregates of iron
oxide NPs. However, the cell behaviour and morphology
of cells treated with dextran-magnetite was different from
the uncoated NP, with the former showing more promi-
nent membrane disruptions (27, 28). They also reported
membrane disruption after exposure to albumin deriva-
tised iron oxide NPs that was attributed to the interaction
between albumin and membrane fatty acids and phos-
pholipids. However, though the uncoated and dextran-
coated iron oxide NP resulted in cytotoxicity (at 50 mg/
ml), the albumin-coated particles did not result in cell
death.
Another cytotoxicity study by Mahmoudi et al. (62)
on a mouse fibroblast cell line showed that the uncoated
particles induce greater toxicity than the biocompatible
polyvinyl alcohol (PVA)-coated particles. However, the
toxicity induced by uncoated particles was significantly
reduced by substitution with surface-saturated uncoated
SPION. The latter SPION were prepared by pre-
incubating the media with the NPs prior to exposure,
which may have resulted in adsorption of biomolecules
onto the SPION surface. Surface saturation with experi-
mental cell medium presumably masks the reactive
surface of the NPs thus preventing the unfavourable
cellnanoparticle or serum proteinnanoparticle interac-
tions that may in turn cause reduced cellular uptake
leading to lower toxicity. The authors also reported the
formation of gas vesicles after exposure to the uncoated
particles; resulting in altered protein functions and
changes in ionic equilibrium within the cells, which
also promotes toxicity. The vesicles were presumed to
be caused by proteinnanoparticle interactions as the
surface-saturated SPION did not cause the formation of
these gas vesicles.
Additionally, the toxicity seemed to be governed by
compositional changes in the media as a result of
the serum proteins binding to the negatively charged
uncoated SPION. This resultant altered composition of
the cell medium to which the cells are exposed presum-
ably results in the observed cytotoxicity (63). This effect
may not be seen in vivo because homeostasis maintained
by the liver and kidneys efficiently regulates any changes
in pH, ionic strength and chemical composition of the
blood plasma.
Apart from the type of surface coating, the tail length
of a coating (for e.g. length of polyethylene oxide, PEO, in
PEO-coated SPION) can bear a negative correlation with
toxicity with the shortest tail of 0.75 kD causing
chromatin condensation, nuclear blebbing and formation
of apoptotic bodies (11). It can be argued that the longer
tails can undergo degradation into shorter tails within the
intracellular milieu and cause toxicity, but the authors
believe that the stable moieties such as ether groups on
PEO and the amide ester bonds on the surface of SPION
could potentially protect the coating from degradation
and enzymatic attack.
Although one of the key mechanisms responsible for
cytotoxicity involves oxidative stress, citrate-coated very
small superparamagnetic iron oxide nanoparticles
(VSOP) have been shown to lead to cellular oxidative
(14) stress in rat macrophages (as shown by a significant
increase in the levels of malonyldialdehyde and protein
carbonyls) without causing any cytotoxic effects. Inter-
estingly, this increase was only transient, as 24-h post-
incubation resulted in a decrease to control levels. This
increased oxidative stress was, however, eliminated by the
iron chelator desferal and the intracellular spin trap PBN
suggesting that iron may have been released from VSOP
at the early stages of incubation and was responsible for
the effects observed.
Similarly, genotoxicity (using the comet assay) using
meso-2,3-dimercaptosuccinic acid (DMSA) coated
SPION was observed at concentrations of 10100 mg/ml
where no significant cytotoxicity occurred (64). The
group also suggested that a surface-coating such as
(DMSA) can inhibit a potential cytotoxic effect by
preventing direct contact between maghemite (Fe2O3)
NPs and human dermal fibroblasts. They showed a
significant decrease in cell viability of fibroblasts upon
exposure to DMSA-coated maghemite (NmDMSA) at
concentrations between 106 and 103 mg/ml. Interest-
ingly, the higher concentration of 100 mg/ml did not show
reduced cell viability; instead it showed a significant
increase in metabolic mitochondrial activity. This finding
was attributed to the increase in aggregate size from 30
nm to 70 nm at higher concentrations resulting in less
effectual contact between NmDMSA and the cells.
Another crucial aspect that demands attention is the
safety of these SPION with regards to the oxidation state
and compositional changes that might occur over time
and affect its shelf-life and toxicity. Magnetite, which is a
Neenu Singh et al.
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mixture of FeO and Fe2O3, is not very stable and can
readily undergo oxidation (from Fe2into Fe3) to form
maghemite in the presence of air, light and moisture (22):
Fe3O42H
 0 gFe2O3Fe
2H2O
Magnetite (Fe3O4) and maghemite (Fe2O3) can show
different cellular responses because of their ability to
undergo oxidation/reduction reactions. In fact, magnetite
has been shown to cause higher levels of oxidative DNA
lesions (using comet assay) in A549 human lung epithelial
cell line in the absence of decreased cell viability as
compared to maghemite owing to its potential to undergo
oxidation (40, 41). It is hypothesised that the toxicity can,
however, be decreased by coating magnetite particles
resulting in fewer oxidative sites that are less reactive and
thereby produce less DNA damage (63).
Interestingly, significant differences in cellular uptake
and DNA damage have been demonstrated depending on
the oxidation state of iron (Fe2 or Fe3) in dextran-
coated iron nanoparticles as analysed by X-ray photo-
electron spectroscopy (XPS) (45). Dextran-coated ma-
ghemite (Fe2O3) with a Fe
2/Fe3 ratio of 0.118 showed
significant genotoxicity, which correlated with cellular
uptake as compared to the dextran-coated magnetite
(Fe3O4) with a Fe
2/Fe3 ratio of 0.435, showing that
Fe3 ions are more potent in inducing DNA damage.
Since human exposure to ferrofluids is predicted to
increase in nanomedicine-based therapeutics, these find-
ings warrant the need to devise adequate testing strategies
in order to ensure that a given ferrofluid has not
incorporated changes in its valence shell that might
influence its cellular interaction and the ensuing down-
stream toxicity. Alternatively, it may be necessary to
design iron NPs that are highly stable chemically and
oxidation resistant without compromising on cellular
damage.
Altered cellular responses
Cellular stress
To date, most studies have only focused on cytotoxicity
induced as a result of exposure to SPION, with very few
considering the effect on other normal cellular and
physiological functions. This is of concern given that
important cellular processes could be impaired but go
unobserved if the focus of most research studies is
confined to more noticeable determinants of gross
toxicity. Since SPION can be coated to cause increased
cellular uptake, Soenen et al. (65) designed a cationic
amphiphile with the aim to maximise internalisation of
SPION without inducing any cytotoxic effects on neural
progenitor cells and human blood outgrowth endothelial
cells. However, high doses of these NPs caused inter-
ference with the actin cytoskeleton resulting in decreased
cell proliferation indicating the possibility that non-toxic
doses could cause other forms of cellular stress.
The same group have demonstrated that magnetolipo-
somes can affect actin cytoskeleton architecture, forma-
tion of focal adhesion complexes and impair cell
proliferation (which took 7 days to return to normal
post-SPION exposure) indicating a longer-term effect of
SPION (66). Another case of SPION-mediated cellular
stress involves disruption of a cytoskeleton protein,
tubulin that has been shown to be associated with the
uptake of transferring-derivatised SPION (67). Apopa
et al. (68) have also reported a similar finding upon
SPION (uncoated maghemite) exposure; they noted that
the dynamic cortical meshwork of F-actin in human
microvascular endothelial cells rearranges and undergoes
polymerisation rapidly in response to extracellular signals
that impinge on the plasma membrane resulting in
increased cell permeability. They demonstrated that
production of ROS by iron-NPs induced GSK-3b inhibi-
tion via activation of the Akt signalling pathway, which is
involved in changes in actin dynamics such as cell
migration that in turn effect chemotaxis, locomotion
and invasion. Apart from its role in altering the
cytoskeleton and its associated processes, Akt is also
known to play a key role in insulin signalling and in
linking growth factor signalling through PI 3-kinase to
basic metabolic functions, such as protein and lipid
synthesis, carbohydrate mechanism and transcription.
Therefore, activation of the Akt pathway by SPION
could potentially lead to perturbation of these normal
biological processes. Another problem associated with
this remodelling is the formation of gaps between
endothelial cells that could lead to extravasation of
unwanted macromolecules or drugs into adjoining areas,
thus having the potential to result in adverse patholgoical
responses.
Changes in gene expression
Organisation of the cytoskeletal structure of F-actin
filaments is an essential element in maintaining and
modulating cellular morphology and structural integrity
(69, 70) and any disruption in its architecture can lead to
alteration in the expression of cytoskeleton-associated
proteins. In fact, microarray analysis subsequent to a 48 h
exposure of SPION on primary human fibroblasts
showed an upregulation in expression of genes involved
in the modulation of actin remodelling. In addition,
SPION exposure also caused the increase in expression of
genes involved in cell signalling, including integrin
subunits, tyrosine kinases and several members of the
protein kinase C family (a/d/u/z), suggesting that SPION
can have an impact on signalling transduction pathways.
Other genes that were upregulated included genes related
to cell movement and interaction such as growth
hormones, ion channels, and Ras-related proteins.
Potential toxicity of SPION
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Furthermore, there were significant increases in ECM
proteins and matrix metalloproteinases, suggesting that
the SPION exposure caused the fibroblasts to reorganise
their matrix material (67).
A study conducted on pancreatic islet cells labelled
with Resovist (carboxydextran-coated SPION; commer-
cially available MRI agent), revealed that insulin expres-
sion in labelled islets was significantly elevated (2 fold)
(71). Beta-cell E-box trans-activator (BETA2) an impor-
tant transcription factor for insulin gene transcription,
was also increased in labelled islets (1.7 fold). However,
no difference was observed between labelled and unla-
belled islets in terms of the ability to secrete insulin, as
determined by the glucose stimulation index. There could
be several ways to explain this: Firstly, before concluding
that iron overload does not influence insulin secretion it
is important to rule out any defects involving desensitisa-
tion of glucose-induced insulin secretion such as expres-
sion levels of glucose transporter-4 that helps in the
facilitated diffusion of glucose. Secondly, since the
primary mechanism of SPION uptake is endocytosis
and insulin is secreted via exocytosis there may be a
possibility that insulin secretion is compromised as a
result of vesicular trafficking in either direction. Finally,
an increase in insulin expression without a concomitant
increase in insulin secretion suggests that longer incuba-
tion times with Resovist may be required for an
observable effect on insulin secretion. On the other
hand, considering that insulin expression is significantly
increased in response to Resovist, it is tempting to
speculate that the incorporation of MRI contrast agents
into pancreatic islets may prove beneficial in diabetic
patients undergoing islet imaging.
However, insulin causes a marked stimulation of iron
uptake by fat cells; also, it can cause an increase in ferritin
synthesis and localisation of transferrin receptors to the
membrane leading to increased iron uptake. Normally the
free iron within cells is stored as an ironferritin complex
to negate the high toxicity associated with free iron.
However, under pathological conditions (such as cancer,
atherosclerosis, hypertension and arthritis), which are
associated with the generation of ROS, iron may effec-
tively be released from ferritin (49, 72). These radicals act
as reducing agents that convert Fe3 to Fe2; the latter
in turn can result in the formation of superoxide anion
and highly reactive OH radical via the Fenton reaction.
This can cause a vicious circle whereby increased insulin
expression by Resovist could potentially cause enhanced
iron uptake that can prove detrimental particularly in a
pathological condition. This could result in iron overload
within the cell and the production and accumulation of
highly toxic free radicals that may in turn attack cell
membranes, DNA and proteins.
Although the expression of two other endocrine
hormones, somatosatin and glucagons, did not change
and the study indicated the safety of using Resovist to
image islets, in our view a watchful eye is warranted for
any deleterious effect particularly where underlying
disease pathologies are involved.
Dextran-coated SPION also have the potential to cause
perturbation in the regulation of iron homeostasis. Indeed
preliminary studies within our group have found that
although ferritin (iron storage protein complex) and
ferroportin (iron export molecule) were not altered
following exposure to dextran-coated SPION, transfer-
rin-receptor 1 (TfR1) and hepcidin were significantly
down-regulated in HepG2 hepatocellular carcinoma cells.
The TfR1 is a cell-surface receptor that controls iron
uptake (73); its down-regulation following exposure to
dextran-coated SPION therefore suggests that the cells
were reacting as though they were in a state of iron
overload (Fig. 4A). Hepcidin is a peptide hormone
secreted by the liver responsible for regulating intestinal
iron absorption. Normally hepcidin blocks ferroportin
inhibiting iron export into the plasma so in normal iron
homeostasis if there is an increase in plasma iron, it
stimulates increased hepcidin release from the liver to
inhibit further release of iron into the plasma from the
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Fig. 4. Preliminary data to demonstrate the effect of
dextran-coated SPION on the expression of genes involved
in iron homeostasis using real-time RT-PCR. (A) TfR1 and
(B) hepcidin. The students’ paired t-test was used to
determine if down-regulation proved to be significant change
in expression (with error bars representing standard devia-
tion (*PB0.05); as compared to the control where water was
used in place of the nanoparticles.
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duodenum and hepatocytes, whilst promoting iron storage
in reticuloendothelial macrophages (74). Our results are
contrary to what would be expected when hepatocytes are
incubated with SPION as a dramatic down-regulation of
hepcidin was observed following exposure to dextran-
coated SPION (Fig. 4B). However, this is not an isolated
observation and several in vitro based studies have found
that iron overload of hepatocytes results in decreased
hepcidin mRNA, where as iron-overload in vivo would
result in increased hepcidin expression (75). It has there-
fore been speculated that there may be other iron-sensing
signals to hepatocytes that induce the production of
hepcidin during iron-overload situations, which is not
mimicked in cell culture (7477). Although further studies
are required to elucidate the mechanisms involved, it can
be speculated that the body might act to reduce dietary
iron uptake, which may in turn lead to conditions such as
anaemia if these nanomaterials aren’t cleared from the
circulation when they’re administered. Therefore, changes
in expression of genes involved in iron metabolism
necessitate the need for more studies in order to
ensure the safety of these agents in various biomedical
applications.
Impact on cell proliferation
Generally, the internalisation of NPs within cells is likely
to occur in a time-dependent manner and after a certain
threshold is reached the uptake is expected to plateau off
when cells have reached a point of maximum saturation.
Similarly, cell viability subsequent to nanoparticle uptake
is expected to be either unaffected or decrease as a
function of time. However, it has been shown by Soenen
et al. (78) that cell viability of 3T3 fibroblasts in response
to cationic magnetoliposomes that contained distearoyl
analogue was augmented as compared to control cells.
The transient cell growth and proliferation observed in
the study may be due to additional nutrients present
within the cells in the form of iron and phospholipids for
the viable cells stimulating cell growth (79). In another
study (67), an increase in cell proliferation in primary
human fibroblasts (hTERT-BJ1) was observed in re-
sponse to transferrin-coated SPION; transferrin, a major
iron transport protein, has been demonstrated to be
important for cellular proliferation (80, 81).
Soenen et al. (78) also provided an explanation for the
bell-shaped curve that was observed in the study that can
be explained as follows: initial lag phase in cellular
activity as the cells have to deal with sudden exposure
and internalisation of NPs, middle log phase marked by a
period (610 h) of cellular growth as the cells resume
their cellular activities and finally the cell number either
stabilises or there is reduced cell viability as a result of cell
toxicity. This stresses the need to follow cell viability over
an extended period of time in order to avoid possible cell
viability artefacts and to accurately ascertain cytotoxicity
of a given nanoparticle. Another important point to
consider is that as cells divide over time the daughter cells
are exposed to relatively low concentrations of NPs due
to the fact that SPIO concentration gets diluted with
successive cell divisions; this could affect various cellular
processes such as cellular uptake, cell viability and cell
toxicity.
A study investigating the toxic effects of Ferucarbotran
(Resovist) on mesenchymal stem cells showed augmented
cell growth and an increase in cell cycle progression via
alterations in the expression of cell cycle regulatory
proteins and by reducing intracellular hydrogen peroxide
(H2O2) (82). The group reported an increased expression
of hyper-phosphorylated retinoblastoma tumour sup-
pressor protein pRb, cyclins and cyclin-dependent ki-
nases, namely cyclins B, D1, E, CDK2 and CDK4. On
the other hand, Ferucarbotran caused decreases in the
expressions of p21Cip1, and p27Kip1, members of the CIP/
KIP family that are negative regulators of the cell cycle.
Furthermore, these SPION decreased the expression of
the tumour suppressor gene, p53. The effects of SPION
labelling on cell cycle regulatory proteins were opposite to
those of iron depletion indicating the involvement of
these proteins in regulating cell cycle progression and cell
growth in response to free iron within the cells (83). Since
SPION can also induce AKT activation (68), there is a
possibility that this pathway is involved in cellular
proliferation and viability following exposure to SPION,
given that the PI3/AKT pathway can cause the cells to
escape apoptosis.
SPION uptake can induce signalling events such as
Akt pathway. Conversely, modulation of signalling mo-
lecules like MAPK pathway can affect its uptake. In a
study conducted on aortic macrophages in a mouse
atherosclerosis model, uptake of intravenously adminis-
tered Feridex (dextran-coated SPION; commercially
available MRI agent) was attenuated by inhibiting the
p38 MAPK demonstrating that SPION uptake or the
macrophage phagocytic activity seeem be regulated by
MAPK signalling pathway (84). This reflects the poten-
tial strategy of using inhibitors (in this case SB239063) for
signalling molecules to modulate SPION-induced macro-
phage toxicity resultant to SPION uptake (85). However,
the pitfall of tampering with signalling molecules in
therapeutic approaches is that the inhibition of one
signalling pathway could lead to the activation of another
pathway. For example, it has been identified that
rapamycin analogs that reduce tumour growth by in-
hibiting the mTOR protein complex 1 (mTORC1), also
activate the MAPK (mitogen-activated protein kinase)
pathway; this inhibits the antitumour activity of rapamy-
cin by encouraging cell survival (86). Further analysis on
mechanisms of SPION uptake will provide insights into
the use of these NPs in therapeutics.
Potential toxicity of SPION
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Ambient exposure
Besides the application of SPIO in a clinical scenario,
safety and toxicological issues with respect to their
presence within our environment also needs to be
considered. SPION can accumulate in organs such as
liver, brain, spleen and lungs subsequent to inhalation
and penetration through hair follicles (87, 88). With
regard to this, Karlsson et al. (20) have shown that
subway particles that are composed of a high percentage
of magnetite can cause genotoxicity via mitochondrial
depolarisation and induction of oxidative stress. Interest-
ingly, even though the iron-rich subway particles caused
a significant increase in oxidative stress (measured by
intracellular ROS) and mitochondrial depolarisation, the
magnetite particles on their own failed to elicit such an
increase in both assays used in this study. Genotoxicity, as
measured by the DNA damage (comet assay), was shown
to be significantly increased in both cases but more so in
the subway particles as compared to the magnetite
particles (240 and 40%, respectively). Despite the subway
particles consisting primarily of iron oxide (as analysed
by X-ray energy dispersive spectrometry), there were
other metal components in the subway particles that
might have interacted and therefore influenced the effects
observed in this study. Hence, the true impact of human
exposure to SPION in the local environment remains to
be determined.
Nanoparticleprotein interactions
Given that the nanoparticleprotein corona is an inevi-
table entity in both in vitro and in vivo biological exposure
scenarios, the transient nature of these associations as
well as the SPIONprotein affinities needs to be thor-
oughly determined (89). This is important especially in a
clinical scenario where the disease status of an individual
(undergoing treatment by ferrofluids) and the associated
altered protein levels governs such interactions. These
interactions may prove unfavourable possibly resulting in
an inefficient uptake or even overload of SPION depend-
ing on the presence of certain proteins in the blood
plasma that may act synergistically with the behaviour of
NPs. Thus, it can be speculated that NPs undergo two
main processes that are important determinants of their
cellular uptake: transient NPprotein binding (in culture
media in vitro or body fluids in vivo) and NPprotein
interaction with cell surface/membrane macromolecules
(89).
Given the possibility that NPs may be small enough to
traverse the blood-brain barrier, there has been concern
that they may induce or abrogate neurological disease,
but this ability may also be used beneficially through the
development of tailor-made nanomedicine for the treat-
ment of such disorders (85). Indeed, a study on protein
amyloid aggregation (a pathology seen in diseases such as
Parkinson’s, Alzheimer’s and type II diabetes) found the
protein aggregates were significantly reduced by magnetic
Fe3O4 NPs. These NPs not only inhibited lysozyme
amyloid aggregation by blocking the nucleation process
but also induced depolymerisation of lysozyme aggre-
gates by interacting with and interrupting the adjoining
protein sheets; lysozyme adsorption seemed to govern
both these processes (90). Currently there are no clinical
drugs to reverse or prevent the formation of aggregates
and based on this study the Fe3O4 NPs could potentially
be used as novel therapeutic agents in the treatment of
protein amyloid aggregation-associated human patholo-
gies (91). This is an interesting finding warranting further
exploration into NPsprotein interactions since protein
adsorption, although beneficial in this example, may also
prove to be detrimental in cases where the protein
phenotype is altered by such interactions in normal cells.
To identify the proteins that associate with SPION,
dextran-coated SPION were incubated with mouse
plasma and despite rigorous washing and their low
abundance in plasma, histidineproline-rich glycoprotein
(HMWK), high molecular weight kininogen and plasma
prekallikrein (KLK) demonstrated a significant strong
affinity towards the NPs (92). All three proteins have
histidine-rich domain and therefore, bind to the nega-
tively charged iron oxide core in SPION with none
binding to neutral dextran coating (93, 94). In order to
identify the weakly bound proteins the washing step was
eliminated, and the analysis of mouse plasma showed
significant amounts of an altogether different profile of
proteins, namely mannose-binding lectin (MBLs), MBL-
associated serine proteases (MASPs), apolipoproteins,
beta-2 glycoprotein and clotting factors FXI and FXII.
Under these less stringent conditions, the most abundant
plasma proteins, albumin and transferrin, did not show
any significant attachment to SPION indicating that the
protein interactions were a selective process. Interestingly,
the study does not support the involvement of plasma
opsonins in the removal of SPION from the circulation
by mice liver macrophages and also indicates that the
plasma protein coating does not interfere with the
interaction between the SPION and macrophage recep-
tors. Thus, in the light of these findings, it is suggested
that the nanoparticle surface is available for interaction
and subsequent uptake by receptors, such as the scaven-
ger receptors. Contrary to these findings, Xie et al. (95)
have shown that in the human serum albumin (HSA)
coated SPION, the HSA-sheath may be directly respon-
sible for the cellular uptake by macrophages as it has
been shown to interact with surface receptors such as
glycoprotein (gp60) receptor and secreted protein acid
and rich in cysteine (SPARC) receptor present on a range
of cell types (96, 97).
The SPION-bound proteins may also impinge on
various biochemical pathways involved in the complement
system activation; MBLs and MASPs could stimulate the
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lectin-complement pathway, and surface bound immuno-
globulins could activate the classical complement pathway,
hence playing a role in nanoparticle toxicity (98, 99).
Additionally, strongly bound proteins (i.e. kininogen and
kallikrein in conjunction with coagulation factors XI and
XII) could potentially trigger the intrinsic pathway of the
coagulation cascade (100).
Conclusion
Given that the variety of medical applications of SPION
require sufficient intracellular uptake for efficient diag-
nosis and treatment, understanding the potential risks
associated with exposure to these NPs and the effect that
the range of surface coatings utilised for functionality is
crucial. In many cases these treatments may be adequately
cleared from the body, but there is the possibility that
cellular SPION overload may trigger adverse cellular
responses and the long-term impact of these acute
exposures are not well understood, thus there is a clear
need to comprehensively investigate and elucidate the
biological consequences of exposure to SPION. It is
critical to design functionalised SPION that can not
only be effectively and sufficiently internalised and are
appropriately magnetisable, but also meet the demands of
a particular application without compromising on cellular
toxicity. For example, biomedical applications, like drug
delivery, require high doses of internalised particles while
for extracellular drug delivery these amounts are not
favourable (101). Improved understanding of biological
impacts will therefore lead to the design of more biocom-
patible nanomaterials that are fit for their function.
It is plausible that internalised SPION may corrode
over a long period of time by releasing metallic ions that
in turn bear a long-established correlation with DNA
damage. Ideally, it would be worthwhile to decipher the
stability and breakdown products of coatings because a
‘biocompatible coating’ that is considered stable initially
may eventually break down into an unfavourable product
or expose the iron oxide core, thereby eliciting adverse
cellular responses. Hence, the stability of functionalised
SPION is another crucial issue to be taken into con-
sideration.
Numerous studies on SPION including those on
commercially available and clinically approved MRI
contrast agents such as Feridex and Resovist have
reported that these NPs are biocompatible and lack
cytotoxicity. At present the measure of biocompatibility
largely focuses on the extent of cytotoxicity observed.
However, the criteria to define toxicity of NPs needs to be
clearly defined (82), particularly as emerging studies have
begun to highlight aberrant cellular responses including
DNA damage, oxidative stress, mitochondrial membrane
dysfunction and changes in gene expression as a result of
SPION exposure, all in the absence of cytotoxicity.
Fig. 5. Schematic representation of SPION-induced toxicity at cellular level. SPION may cause direct DNA damage or result in
the generation of oxidative radicals that in turn have the potential to cause DNA damage (indirect), have an impact on actin
cytoskeleton by modulating the Akt signalling pathway, and also alter the expression of various genes such as those involved in
cell cycle regulation, iron homeostasis and pancreatic functioning.
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Hence, terms such as ‘biocompatibility’ need to be re-
evaluated when commenting on the safety of these
SPION agents.
Our current lack of understanding of the health
impacts following exposure to nanomaterials requires
adequate testing strategies. Where there is clear evidence
of hazard or the people involved are endangered, regula-
tions need to be addressed and continually assessed as
each new nanomedicine application evolves. With regards
to SPION, there are a number of issues that clearly need
be addressed by the scientific community prior to
approving their clinical use:
1. How much access do SPION have to tissues and
organs other than the ones being treated or inves-
tigated and how long after are they eliminated from
the different tissues/organs and the body in general?
2. What impact would the SPION have on the
morphology (e.g. actin polymerisation) and/or func-
tions (e.g. gene expression) of the exposed cells and
are the subtle but deleterious alterations, such as
DNA damage and oxidative lesions (if any) being
thoroughly investigated (Fig. 5)?
3. Could the SPION degradation that presumably
occurs in the lysosomes, with the resultant genera-
tion of iron ions, have impact on various cellular
processes (26, 55, 60, 61, 82)? Chen et al. (102) have
recently demonstrated that Ferucarbotran can
promote cell migration, activate signalling protein
molecules, and inhibit osteogenesis in human me-
senchymal stem cells, all of which were attributed to
the generation of free iron from Ferucarbotran
degradation.
4. Are the internal organs and the cellular machinery
equipped to deal with the processing of SPION
(both coated and uncoated) with a range of physico-
chemical characteristics?
5. Does iron homeostasis play the same role every time
it encounters a SPION irrespective of its physico-
chemical characteristics?
6. Are the different SPION being processed by the
intracellular pathways (e.g. endocytotic pathway) in
the same sequential manner in all tissues or is their
fate cell/tissue dependent?
7. Do they have a precise location upon entry within
the cells and is the uptake and subcellular localisa-
tion dependent on size and/or surface coating (103)?
An interesting observation noted by Song et al.
(104) was that short iron nanowires accumulated in
the vesicles of HeLa cells by non-specific pinocyto-
sis, while long iron nanowires perforated and
diffused through the lipid bilayer membrane and
only penetrated as far as the cytoplasm thereby
demonstrating the impact of physical features on
uptake mechanisms and sites of accumulation.
8. How does the coating of SPION influence their
interaction with the proteins and other biological
entities within the cellular milieu?
These issues demand attention not only to ensure the
safer use of SPION in nanomedicine, but are essential in
establishing novel targeted therapies with improved
design that are able to deliver their beneficial promises
to the medical world.
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